| 1 | BCL10, CARD14, MALT1
|
| Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease
|
| Mellett M.
|
| Cell Immunol. Aug;354:104147. doi: 10.1016/j.cellimm.2020.104147. Epub 2020 Jun 13 2020
|
| 2 | BCL10, CARD14, MALT1
|
| CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis
|
| Van Nuffel E, Schmitt A, Afonina IS, Schulze-Osthoff K, Beyaert R, Hailfinger S.
|
| J Invest Dermatol. Mar;137(3):569-575. doi: 10.1016/j.jid.2016.09.031. Epub 2016 Dec 8. 2017
|
| 3 | BCL10, CARD11, MALT1
|
| Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
|
| Steinhardt JJ, Peroutka RJ, Mazan-Mamczarz K, Chen Q, Houng S, Robles C, Barth RN, DuBose J, Bruns B, Tesoriero R, Stein D, Fang R, Hanna N, Pasley J, Rodriguez C, Kligman MD, Bradley M, Rabin J, Shackelford S, Dai B, Landon AL, Scalea T, Livak F, Gartenhaus RB.
|
| Blood 124(25):3758-67. doi: 10.1182/blood-2014-07-589689. Epub 2014 Oct 15.
2014
|
| 4 | AIP, BCL10, CARD11, MALT1
|
| AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation.
|
| Schimmack G, Eitelhuber AC, Vincendeau M, Demski K, Shinohara H, Kurosaki T, Krappmann D.
|
| Cell Commun Signal 12:49. doi: 10.1186/s12964-014-0049-7.
2014
|
| 5 | BCL10, RNF168, RNF8, UBE2N
|
| BCL10 regulates RNF8/RNF168-mediated ubiquitination in the DNA damage response.
|
| Zhao H, Zhu M, Dou G, Zhao H, Zhu B, Li J, Liao J, Xu X.
|
| Cell Cycle 13(11):1777-87. doi: 10.4161/cc.28707. Epub 2014 Apr 14.
2014
|
| 6 | BCL10, CRADD
|
| The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.
|
| Qiao H, Liu Y, Veach RA, Wylezinski L, Hawiger J.
|
| J Biol Chem 289(32):21973-83. doi: 10.1074/jbc.M114.588723.
2014
|
| 7 | BCL10, IMD37
|
| Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.
|
| Torres JM, Martinez-Barricarte R, García-Gómez S, Mazariegos MS, Itan Y, Boisson B, Rholvarez R, Jiménez-Reinoso A, del Pino L, Rodríguez-Pena R, Ferreira A, Hernández-Jiménez E, Toledano V, Cubillos-Zapata C, Díaz-Almirón M, López-Collazo E, Unzueta-Roch JL, Sánchez-Ramón S, Regueiro JR, López-Granados E, Casanova JL, Pérez de Diego R.
|
| J Clin Invest 124(12):5239-48. doi: 10.1172/JCI77493. Epub 2014 Nov 3.
2014
|
| 8 | BCL10, CARD11, MALT1
|
| Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly.
|
| Qiao Q, Yang C, Zheng C, Fontán L, David L, Yu X, Bracken C, Rosen M, Melnick A, Egelman EH, Wu H.
|
| Mol Cell 51(6):766-79. doi: 10.1016/j.molcel.2013.08.032.
2013
|
| 9 | BCL10, CARD11
|
| Self-oligomerization of the CARD domain prevents complex formation in the CARMA1 signalosome.
|
| Park JH, Bae JY, Park HH.
|
| Int J Mol Med 31(5):1280-7. doi: 10.3892/ijmm.2013.1307. Epub 2013 Mar 19.
2013
|
| 10 | BCL10, CARD11, MALT1
|
| Structural insights into the assembly of CARMA1 and BCL10.
|
| Li S, Yang X, Shao J, Shen Y.
|
| PLoS One 7(8):e42775. doi: 10.1371/journal.pone.0042775. Epub 2012 Aug 3.
2012
|
| 11 | BCL10, CARD10
|
| CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
|
| Jiang T, Grabiner B, Zhu Y, Jiang C, Li H, You Y, Lang J, Hung MC, Lin X.
|
| Cancer Res 71(6):2183-92.
2011
|
| 12 | BCL10, CAMK2G
|
| CaMKII targets Bcl10 in T-cell receptor induced activation of NF-κB.
|
| Oruganti SR, Edin S, Grundström C, Grundström T.
|
| Mol Immunol 48(12-13):1448-60. Epub 2011 Apr 22.
2011
|
| 13 | BCL10, CARD9, MALT1, SYK
|
| The SYK tyrosine kinase: a crucial player in diverse biological functions.
|
| Mócsai A, Ruland J, Tybulewicz VL.
|
| Nat Rev Immunol 10(6):387-402. Review. 2010
|
| 14 | BCL10, CARD10, MALT1
|
| The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.
|
| McAllister-Lucas LM, Jin X, Gu S, Siu K, McDonnell S, Ruland J, Delekta PC, Van Beek M, Lucas PC.
|
| J Biol Chem 285(34):25880-4. Epub 2010 Jul 5.
2010
|
| 15 | BCL10
|
| Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
|
| Edin S, Oruganti SR, Grundström C, Grundström T.
|
| Mol Immunol 47(11-12):2057-64. Epub 2010 May 1.
2010
|
| 16 | BCL10, CARD11, MALT1
|
| COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
|
| Welteke V, Eitelhuber A, Düwel M, Schweitzer K, Naumann M, Krappmann D.
|
| EMBO Rep 10(6):642-8. Epub 2009 May 15.
2009
|
| 17 | BCL10, STAT5B
|
| STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.
|
| Nagy ZS, LeBaron MJ, Ross JA, Mitra A, Rui H, Kirken RA.
|
| Mol Cancer 8:67.
2009
|
| 18 | BCL10
|
| Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome.
|
| Briones J, Moga E, Espinosa I, Vergara C, Alvarez E, Villa J, Bordes R, Delgado J, Prat J, Sierra J.
|
| Histopathology 54(4):478-85.
2009
|
| 19 | BCL10, MALT1
|
| Multiple protein domains mediate interaction between Bcl10 and MALT1.
|
| Langel FD, Jain NA, Rossman JS, Kingeter LM, Kashyap AK, Schaefer BC.
|
| J Biol Chem 283(47):32419-31. Epub 2008 Sep 19.
2008
|
| 20 | BCL10, CARD11, MALT1
|
| The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
|
| McCully RR, Pomerantz JL.
|
| Mol Cell Biol 28(18):5668-86. Epub 2008 Jul 14.
2008
|
| 21 | BCL10, CARD10, TNFAIP3
|
| A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
|
| Stilo R, Varricchio E, Liguoro D, Leonardi A, Vito P.
|
| J Cell Sci 121(Pt 8):1165-71. Epub 2008 Mar 18.
2008
|
| 22 | BCL10
|
| Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production.
|
| Klemm S, Zimmermann S, Peschel C, Mak TW, Ruland J.
|
| Proc Natl Acad Sci U S A 104(1):134-8. Epub 2006 Nov 9. 2007
|
| 23 | BCL10
|
| Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors.
|
| Wang D, You Y, Lin PC, Xue L, Morris SW, Zeng H, Wen R, Lin X.
|
| Proc Natl Acad Sci U S A 104(1):145-50. Epub 2006 Dec 19. Erratum in: Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):2024. 2007
|
| 24 | CARD10, BCL10, MALT1
|
| CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
|
| McAllister-Lucas LM, Ruland J, Siu K, Jin X, Gu S, Kim DS, Kuffa P, Kohrt D, Mak TW, Nunez G, Lucas PC.
|
| Proc Natl Acad Sci U S A 104(1):139-44. Epub 2006 Nov 13. 2007
|
| 25 | MALT1, BCL10, FOXP1, MALTLY, MALTL
|
| MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
|
| Borovecki A, Korac P, Ventura RA, Perisa MM, Banham AH, Dominis M.
|
| Pathol Int 57(1):47-51. 2007
|
| 26 | BCL10
|
| BCL10 gene amplification associated with strong nuclear BCL10 expression in a diffuse large B cell lymphoma with IGH-BCL2 fusion.
|
| Ye H, Gesk S, Martin-Subero JI, Nader A, Du MQ, Siebert R.
|
| Haematologica 91(6 Suppl):ECR28. 2006
|
| 27 | MALT1, BCL10, MALTL, MALTLY
|
| MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells.
|
| Sagaert X, Laurent M, Baens M, Wlodarska I, De Wolf-Peeters C.
|
| Mod Pathol 19(2):225-32. 2006
|
| 28 | MALT1, MALTLY, BCL10, MALTL
|
| MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10.
|
| Nakagawa M, Hosokawa Y, Yonezumi M, Izumiyama K, Suzuki R, Tsuzuki S, Asaka M, Seto M.
|
| Blood 106(13):4210-6. Epub 2005 Aug 25. 2005
|
| 29 | MALT1, BCL10 ,MALTlL, MALTLY
|
| MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
|
| Ye H, Gong L, Liu H, Hamoudi RA, Shirali S, Ho L, Chott A, Streubel B, Siebert R, Gesk S, Martin-Subero JI, Radford JA, Banerjee S, Nicholson AG, Ranaldi R, Remstein ED, Gao Z, Zheng J, Isaacson PG, Dogan A, Du MQ.
|
| J Pathol 205(3):293-301. 2005
|
| 30 | BCL10
|
| Molecular cytogenetic characterization of Sezary syndrome.
|
| Mao X, Lillington DM, Czepulkowski B, Russell-Jones R, Young BD, Whittaker S.
|
| Genes Chromosomes Cancer 36(3):250-60. Review. 2003
|
| 31 | BCL10
|
| BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression.
|
| Maes B, Demunter A, Peeters B, De Wolf-Peeters C.
|
| Blood 99(4):1398-404. 2002
|
| 32 | BCL10, CARD11
|
| Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation.
|
| Gaide O, Martinon F, Micheau O, Bonnet D, Thome M, Tschopp J.
|
| FEBS Lett 496(2-3):121-7. 2001
|
| 33 | BCL10
|
| T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10.
|
| iu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG, Du MQ.
|
| Blood 98(4):1182-7. 2001
|
| 34 | BCL10
|
| BCL10 gene mutation in lymphoma.
|
| Du MQ, Peng H, Liu H, Hamoudi RA, Diss TC, Willis TG, Ye H, Dogan A, Wotherspoon AC, Dyer MJ, Isaacson PG.
|
| Blood 95(12):3885-90. 2000
|
| 35 | BCL10, CARD10, CARD11, NLRC4, CARD14, NOD1, NOD2, CARD9, RIPK2
|
| Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation.
|
| Guiet C, Vito P.
|
| J Cell Biol 148(6):1131-40. 2000
|
| 36 | BCL10, MALTL
|
| Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
|
| Willis TG, et al.
|
| Cell 96(1):35-45. 1999
|
| 37 | BCL10, MALTL
|
| Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
|
| Zhang Q, et al.
|
| Nat Genet 22(1):63-8. 1999
|
| 38 | BCL10
|
| Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
|
| Lee SH, Shin MS, Kim HS, Park WS, Kim SY, Lee HK, Park JY, Oh RR, Jang JJ, Park KM, Han JY, Kang CS, Lee JY, Yoo NJ.
|
| Cancer Res 59(22):5674-7. 1999
|
| 39 | BCL10, MALTL
|
| Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
|
| Takahashi H, Hosokawa Y, Suzuki R, Morishima Y, Nakamura S, Seto M.
|
| Jpn J Cancer Res 90(12):1316-20. 1999
|
| 40 | BCL10
|
| Lack of BCL10 mutations in germ cell tumors and B cell lymphomas.
|
| Fakruddin JM, Chaganti RS, Murty VV.
|
| Cell 97(6):683-4; discussion 686-8. No abstract available. 1999
|
| 41 | BCL10
|
| Absence of BCL10 mutations in human malignant mesothelioma.
|
| Apostolou S, De Rienzo A, Murthy SS, Jhanwar SC, Testa JR.
|
| Cell 97(6):684-6; discussion 686-8. No abstract available. 1999
|
| 42 | BCL10, LFS1, LFS2
|
| Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
|
| Stone JG, Eeles RA, Sodha N, Murday V, Sheriden E, Houlston RS.
|
| Cancer Lett 147(1-2):181-5. 1999
|
| 43 | BCL10
|
| CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis.
|
| Srinivasula SM, Ahmad M, Lin JH, Poyet JL, Fernandes-Alnemri T, Tsichlis PN, Alnemri ES.
|
| J Biol Chem 274(25):17946-54. 1999
|
| 44 | BCL10
|
| CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10.
|
| Koseki T, Inohara N, Chen S, Carrio R, Merino J, Hottiger MO, Nabel GJ, Nunez G.
|
| J Biol Chem 274(15):9955-61. 1999
|
| 45 | BCL10
|
| Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma.
|
| Peng H, et al.
|
| Histopathology 30(5):425-9. 1997
|
| 46 | BCL10
|
| Primary gastric lymphoma.
|
| Isaacson PG.
|
| Br J Biomed Sci 52(4):291-6. Review. 1995
|